BioRestorative Therapies (BRTX) Research & Development (2011 - 2025)
BioRestorative Therapies (BRTX) recorded Research & Development of $2.63 million in Q4 2025, up 54.3% from $1.7 million a year earlier and up 1.2% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Research & Development (2011 - 2025) Analysis & Trends
For FY2025, BioRestorative Therapies reported Research & Development of $10.09 million, up 50.5% from FY2024.
- Annual Research & Development has increased for four straight years, with a five-year compound annual growth rate of 63.0% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $6.71 million in FY2024 (+66.2%), $4.03 million in FY2023 (+14.8%), $3.51 million in FY2022 (+381.9%) and $729,058 in FY2021 (-16.9%).
- The Q4 2025 figure is the highest quarterly Research & Development in data going back to Q4 2011.
- On a year-over-year basis, Research & Development has increased for seven consecutive quarters, with growth averaging 53.8% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 568.3% in Q2 2022, against a decline of 38.5% in Q2 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.59 million (Q3 2025), $2.23 million (Q2 2025) and $1.71 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | BioRestorative Therapies | 687,973.67 | -23.25 Mn | 17,964.00 | 2.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.63 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 809,824.00 |
| Jun 30, 2023 | 902,891.00 |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 673,621.00 |
| Sep 30, 2022 | 989,170.00 |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 775,337.00 |
| Dec 31, 2021 | 165,496.00 |
| Sep 30, 2021 | 237,410.00 |
| Jun 30, 2021 | 160,898.00 |
| Mar 31, 2021 | 165,254.00 |
API Access
BioRestorative Therapies Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();